Cite
Cannabinoid receptor type 2 expression in relapsing-remitting multiple sclerosis
MLA
Gonzalez Perez, P., et al. Cannabinoid Receptor Type 2 Expression in Relapsing-Remitting Multiple Sclerosis. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..a908928553cbe43207ac8b3569614328&authtype=sso&custid=ns315887. Accessed 22 Oct. 2024.
APA
Gonzalez Perez, P., Antonio José Sánchez López, Garcia, V., Ramil, E., & Garcia-Merino, A. (n.d.). Cannabinoid receptor type 2 expression in relapsing-remitting multiple sclerosis.
Chicago
Gonzalez Perez, P., Antonio José Sánchez López, V. Garcia, E. Ramil, and A. Garcia-Merino. 2024. “Cannabinoid Receptor Type 2 Expression in Relapsing-Remitting Multiple Sclerosis.” Accessed October 22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..a908928553cbe43207ac8b3569614328&authtype=sso&custid=ns315887.